Linda and the MHRA are good at clouding whether they are moving deck chairs versus finally contacting rubber tires to the proverbial road.
That is both their long standing problem, our problem and patients’ problem. Shorts and bears financially won many times over the years. For the most part, long investors are awaiting commercial patient access accompanied by massive support (examples: follow-up reimbursement, partnering, indication expansion).
Our latest hope is that Ms. Jenkins signals the real deal is at hand, and will move us forward with multi-pronged moves upon initial market approval — including but not limited to facilitating significant initial funding arrangements and milestone incentives for additional planned endeavors.
Market Data 
Markets 
